Turing Pharma Jacks Up Life-saving Drug by 5000 Percent

Sep 22, 2015

New York Times

According to a New York Times article, specialists in infectious disease are protesting a huge increase in the price of a 62-year-old drug that treats life-threatening parasitic infections.

Turing Pharmaceuticals acquired the drug Daraprim in August. The company almost immediately raised the tablet price from $13.50 to $750 -- an increase of 5,000% for the course of the drugs treatment cycle -- which brings the annual cost of treatment for some patients to hundreds of thousands of dollars, the article said.

Turing’s price increase is not an isolated example. Read the full story to learn more

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments